Does ADO-TRASTUZUMAB EMTANSINE Cause Off label use? 630 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 630 reports of Off label use have been filed in association with ADO-TRASTUZUMAB EMTANSINE. This represents 7.2% of all adverse event reports for ADO-TRASTUZUMAB EMTANSINE.
630
Reports of Off label use with ADO-TRASTUZUMAB EMTANSINE
7.2%
of all ADO-TRASTUZUMAB EMTANSINE reports
165
Deaths
251
Hospitalizations
How Dangerous Is Off label use From ADO-TRASTUZUMAB EMTANSINE?
Of the 630 reports, 165 (26.2%) resulted in death, 251 (39.8%) required hospitalization, and 17 (2.7%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADO-TRASTUZUMAB EMTANSINE. However, 630 reports have been filed with the FAERS database.
What Other Side Effects Does ADO-TRASTUZUMAB EMTANSINE Cause?
Nausea (780)
Fatigue (774)
Disease progression (750)
Diarrhoea (654)
Thrombocytopenia (519)
Death (509)
Neuropathy peripheral (506)
Headache (465)
Platelet count decreased (453)
Metastases to central nervous system (386)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ADO-TRASTUZUMAB EMTANSINE Alternatives Have Lower Off label use Risk?
ADO-TRASTUZUMAB EMTANSINE vs ADRIAMYCIN
ADO-TRASTUZUMAB EMTANSINE vs ADUCANUMAB
ADO-TRASTUZUMAB EMTANSINE vs ADUCANUMAB-AVWA
ADO-TRASTUZUMAB EMTANSINE vs ADVAIR
ADO-TRASTUZUMAB EMTANSINE vs ADVAIR HFA